Article
Research progress on mechanisms and predictive biomarkers for immune-related adverse events
2023-01-25
Abstract excerpt
<title>Abstract</title> <p>In recent years, immune checkpoint inhibitors (ICIs) have been widely used in patients with malignant tumors. While ICIs significantly improve the prognosis of cancer patients, immune-related adverse events (irAEs) also occur. It is currently believed that the occurrence of irAEs correlates with alterations in the body's autoimmune system function, including over-activation of the immun...
Identifiers and source
- Literature Corpus work
- 25e4e4d3-81fa-561d-bd21-2ba10f198ef9
- DOI
- 10.21203/rs.3.rs-2494743/v1
